Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin

Cytokine

Volumn 44, Issue 3, 2008, Pages 392-396

  Nikolaeva, Lyudmila G ^a   Maystat, Tatiana V ^a   Pylypchuk, Volodymyr S ^b   Volyanskii, Yuri L ^c   Frolov, Valery M ^d   Kutsyna, Galyna A ^d  

^a KHARKIV MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^b Ekomed LLC   (Ukraine)

^c The National Academy of Medical Sciences of Ukraine   (Ukraine)

^d Lugansk State Medical University   (Ukraine)

Author keywords

AIDS; Botanical; Herbal; Immunotherapy; XDR

Indexed keywords

ALPHA INTERFERON; ANEMIN; DZHERELO; ETHAMBUTOL; GAMMA INTERFERON; HERBACEOUS AGENT; INTERLEUKIN 2; INTERLEUKIN 6; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; ANTITUBERCULAR AGENTS; CYTOKINES; HIV INFECTIONS; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; TUBERCULOSIS, PULMONARY;

EID: 57449101618     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.10.009     Document Type: Article

References (30)

1. Sahiratmadja E., Alisjahbana B., de Boer T., Adnan I., Maya A., Danusantoso H., et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 75 (2007) 820-829
2. Bai X., Wilson S.E., Chmura K., Feldman N.E., and Chan E.D. Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis (Edinb) 84 6 (2004) 375-385
3. Barnes P.F. Immunotherapy for tuberculosis: wave of the future or tilting at windmills?. Am J Resp Crit Care Med 168 (2003) 142-143
4. Surcel H.M., Troye-Blomberg M., Paulie S., Andersson G., Moreno C., Pasvol G., et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81 (1994) 171-176
5. Bal A.M., Lakhashe S.K., Thakar M.R., Tripathy S.P., and Paranjape R.S. Dysregulation of proinflammatory and regulatory cytokines in HIV infected persons with active tuberculosis. Cytokine 30 (2005) 275-281
6. Demissie A., Abebe M., Aseffa A., Rook G., Fletcher H., Zumla A., et al. VACSEL Study. Group Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 172 (2004) 6938-6943
7. Melnik VP, Panasyuk OV, Pylypchuk VS, Moshich OP, Procenko NM, Leonenko OM. Deployment of herbal preparations Dzherelo and Svitanok for combination therapy of pulmonary tuberculosis. Medical Institute of Ukrainian Association of People's Medicine. Information Bulletin of the Ministry of Health of Autonomous Republic of Crimea. UDK:616.24-002.5-085-038:615.017. 1999. Kiev, Ukraine.
8. Chechitiany R., Pylypchuk V., Arjanova O., Prihoda N., Vihrova L., Zagaydanova E., et al. Comparative effect of an immunomodulator Immunoxel (Dzherelo) when used alone or in combination with antiretroviral therapy in drug-naïve HIV infected individuals. Int. J Biotechnol 9 (2007) 267-276
9. Prihoda N.D., Arjanova O.V., Yurchenko L.V., Sokolenko N.I., Vihrova L.A., Pylypchuk V.S., et al. Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOT. J Med Plant Res 1 (2007) 117-122
10. Prihoda N.D., Arjanova O.V., Yurchenko L.V., Sokolenko N.I., Vihrova L.A., Pylypchuk V.S., et al. Adjuvant immunotherapy of tuberculosis in drug-resistant TB and TB/HIV co-infected patients. Intl J Biomed Pharm Sci 2 (2008) 59-64
11. Nikolaeva L.G., Maystat T.V., Pylypchuk V.S., Volyanskii Y.u.L., Masyuk L.A., and Kutsyna G. Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients. Drug Design Dev Ther 2 (2008) 87-93
12. Nikolaeva L.G., Maystat T.V., Pylypchuk V.S., Volyanskii Y.u.L., Masyuk L.A., and Kutsyna G.A. Effect of oral immunomodulator Dzherelo (Immunoxel) in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS. Intl Immunopharmacol 8 (2008) 845-851
13. Kaufmann S.H. Tuberculosis: back on the immunologists' agenda. Immunity 24 (2006) 351-357
14. Wallis R.S. Reconsidering adjuvant immunotherapy for tuberculosis. Clin Infect Dis 41 (2005) 201-208
15. Toossi Z., Kleinhenz M.E., and Ellner J.J. Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 163 (1986) 1162-1172
16. Hussain R., Kaleem A., Shahid F., Dojki M., Jamil B., Mehmood H., et al. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 264 (2002) 95-108
17. Nagabhushanam V., Solache A., Ting L.M., Escaron C.J., Zhang J.Y., and Ernst J.D. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J Immunol 171 (2003) 4750-4757
18. Bourgarit A., Carcelain G., Martinez V., Lascoux C., Delcey V., Gicquel B., et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20 (2006) F1-F7
19. Giosué S., Casarini M., Alemanno L., Galluccio G., Mattia P., Pedicelli G., et al. Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 158 (1998) 1156-1162
20. Carmona L., Gómez-Reino J.J., Rodríguez-Valverde V., Montero D., Pascual-Gómez E., Mola E.M., et al. BIOBADASER Group. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52 (2005) 1766-1772
21. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 (1993) 2249-2254
22. Belosevic M., Davis C.E., Meltzer M.S., and Nacy C.A. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J Immunol 141 (1988) 890-896
23. Condos R., Rom W.N., and Schluger N.W. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 349 (1997) 1513-1515
24. Milanés-Virelles M.T., García-García I., Santos-Herrera Y., Valdés-Quintana M., Valenzuela-Silva C.M., Jiménez-Madrigal G., et al. MACGAM Study Group. Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study. BMC Infect Dis 8 (2008) 17
25. Jacobs M., Togbe D., Fremond C., Samarina A., Allie N., Botha T., et al. Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect 9 (2007) 623-628
26. Wallis R.S. Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma. J Invest Dermatol Symp Proc 12 (2007) 16-21
27. Rook G.A. Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med 7 (2007) 327-337
28. Djoba Siawaya J.F., Ruhwald M., Eugen-Olsen J., and Walzl G. Correlates for disease progression and prognosis during concurrent HIV/TB infection. Int J Infect Dis 11 (2007) 289-299
29. Santos P., Cunha A., Lopes J., Domingos A., Regateiro F., and Segorbe-Luís A. Gene expression profiling by real-time system PCR analysis in hiv negative patients with multidrug-resistant tuberculosis. Rev Port Pneumol 9 (2003) 14-15
30. Jacobsen M., Repsilber D., Gutschmidt A., Neher A., Feldmann K., Mollenkopf H.J., et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 85 (2007) 613-621